• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by PPD, Inc.

    12/9/21 5:06:56 PM ET
    $PPD
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $PPD alert in real time by email
    SC 13G 1 d251725dsc13g.htm SC 13G SC 13G

     

     

    Securities and Exchange Commission

    Washington, D.C. 20549

     

     

    Schedule 13G

    (Rule 13d-102)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed

    Pursuant to § 240.13d-2

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No.    )*

     

     

    PPD, Inc.

    (Name of Issuer)

    Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    69355F102

    (CUSIP Number)

    December 8, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 69355F102    Schedule 13G    Page 1 of 15

     

      1    

      Names of Reporting Persons

     

      The Carlyle Group Inc.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      CO


    CUSIP No. 69355F102    Schedule 13G    Page 2 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Group Management L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 3 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Holdings II GP L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 4 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Holdings II L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 5 of 15

     

      1    

      Names of Reporting Persons

     

      CG Subsidiary Holdings L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 6 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group Cayman Investment Holdings, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 7 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group Cayman Investment Holdings Sub L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 8 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group VI, L.L.C.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 69355F102    Schedule 13G    Page 9 of 15

     

      1    

      Names of Reporting Persons

     

      TC Group VI, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 10 of 15

     

      1    

      Names of Reporting Persons

     

      Carlyle Partners VI Holdings II, L.P.

      2  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With

       5     

      Sole Voting Power

     

      0

       6   

      Shared Voting Power

     

      0

       7   

      Sole Dispositive Power

     

      0

       8   

      Shared Dispositive Power

     

      0

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      0

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      Not Applicable

    11  

      Percent of Class Represented by Amount in Row 9

     

      0%

    12  

      Type of Reporting Person

     

      PN


    CUSIP No. 69355F102    Schedule 13G    Page 11 of 15

     

    ITEM 1. (a)

    Name of Issuer:

    PPD, Inc. (the “Issuer”)

     (b) Address of Issuer’s Principal Executive Offices:

    929 North Front Street

    Wilmington, NC 28401

     

    ITEM 2. (a)

    Name of Person Filing:

    Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This statement is filed on behalf of:

    Carlyle Group Management L.L.C.

    The Carlyle Group Inc.

    Carlyle Holdings II GP L.L.C.

    Carlyle Holdings II L.L.C.

    CG Subsidiary Holdings L.L.C.

    TC Group Cayman Investment Holdings, L.P.

    TC Group Cayman Investment Holdings Sub L.P.

    TC Group VI, L.L.C.

    TC Group VI, L.P.

    Carlyle Partners VI Holdings II, L.P.

     (b) Address or Principal Business Office:

    The address for each of TC Group Cayman Investment Holdings, L.P. and TC Group Cayman Investment Holdings Sub L.P. is c/o Walkers, 190 Elgin Avenue, George Town, Grand Cayman KY1-9001, Cayman Islands. The address for each of the remaining Reporting Persons is c/o The Carlyle Group Inc., 1001 Pennsylvania Avenue NW, Suite 220 South, Washington, D.C. 20004-2505.

     (c) Citizenship of each Reporting Person is:

    Each of TC Group Cayman Investment Holdings, L.P. and TC Group Cayman Investment Holdings Sub L.P. is organized under the laws of the Cayman Islands. Each of the remaining Reporting Persons is organized under the laws of the state of Delaware.

     (d) Title of Class of Securities:

    Common stock, par value $0.01 per share (“Common Stock”).


    CUSIP No. 69355F102    Schedule 13G    Page 12 of 15

     

    (e) CUSIP Number:

    69355F102

     

    ITEM 3.

    Not applicable.

     

    ITEM 4.

    Ownership.

    (a-c)

    This amendment to Schedule 13G is being filed on behalf of the Reporting Persons to report that, as of December 8, 2021, the Reporting Persons do not beneficially own any shares of Common Stock.

     

    ITEM 5.

    Ownership of Five Percent or Less of a Class.

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    ITEM 6.

    Ownership of More than Five Percent on Behalf of Another Person.

    Not applicable.

     

    ITEM 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

    Not applicable.

     

    ITEM 8.

    Identification and Classification of Members of the Group.

    Not applicable.

     

    ITEM 9.

    Notice of Dissolution of Group.

    Not applicable.

     

    ITEM 10.

    Certification.

    Not applicable.


    CUSIP No. 69355F102    Schedule 13G    Page 13 of 15

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: December 9, 2021

     

    Carlyle Group Management L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Chief Financial Officer
    The Carlyle Group Inc.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director and Chief Financial Officer
    Carlyle Holdings II GP L.L.C.
    By: The Carlyle Group Inc., its sole member
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director and Chief Financial Officer
    Carlyle Holdings II L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    CG Subsidiary Holdings L.L.C.
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director


    CUSIP No. 69355F102    Schedule 13G    Page 14 of 15

     

    TC Group Cayman Investment Holdings, L.P.
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    TC Group Cayman Investment Holdings Sub L.P.
    By: TC Group Cayman Investment Holdings, L.P., its general partner
    By: CG Subsidiary Holdings L.L.C., its general partner
    By:  

    /s/ Anne Frederick, attorney-in-fact

    Name:   Curtis L. Buser
    Title:   Managing Director
    TC Group VI, L.L.C.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person
    TC Group VI, L.P.
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person
    Carlyle Partners VI Holdings II, L.P.
    By: TC Group VI, L.P., its general partner
    By:  

    /s/ Jeremy W. Anderson

    Name:   Jeremy W. Anderson
    Title:   Authorized Person


    CUSIP No. 69355F102    Schedule 13G    Page 15 of 15

     

    LIST OF EXHIBITS

     

    Exhibit No.

      

    Description

    24    Power of Attorney (incorporated by reference to Exhibit 24 to the Schedule 13G filed by the Reporting Persons on February 12, 2021).
    99    Joint Filing Agreement (incorporated by reference to Exhibit 99 to the Schedule 13G filed by the Reporting Persons on February 12, 2021).
    Get the next $PPD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PPD

    DatePrice TargetRatingAnalyst
    8/5/2021$47.50Neutral
    Credit Suisse
    More analyst ratings

    $PPD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Saama Appoints Scott Rogers as Company's Chief Financial Officer

      Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers, 17-year industry veteran, has been appointed as the company's Chief Financial Officer, effective January 31, 2022. In this position Scott is responsible for leading the company's global finance organization and will report to Saama Founder and CEO Suresh Katta. Scott comes to Saama with significant financial executive experience in clinical development, commercial growth, and financial reporting and compliance. He progressed rapidly through the

      2/2/22 8:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Thermo Fisher Scientific Completes Acquisition of PPD, Inc.

      WALTHAM, Mass., Dec. 8, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has completed its acquisition of PPD, Inc. (NASDAQ:PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. "We are very excited to officially welcome our PPD colleagues to Thermo Fisher Scientific," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific. "Expanding our value proposition for our biotech and pharmaceutical customers with the addition of PPD's leading clinical research services advances our work in bringing life-changing therapi

      12/8/21 8:45:00 AM ET
      $PPD
      $TMO
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Industrial Machinery/Components
      Industrials
    • PPD Named to 'Best Workplaces in Greater China' for Second Consecutive Year

      PPD, Inc. (NASDAQ:PPD) was named one of the "Best Workplaces in Greater China™ 2021" by Great Place to Work® for successfully creating an inclusive workplace experience for employees. PPD has more than 20 years of experience in the Asia-Pacific region, including providing a broad range of clinical development and laboratory services in Greater China. This is the second year PPD has received this recognition from Great Place to Work®, a global authority on high-trust, high-performance workplace cultures. "We remain committed to providing a healthy and open work environment for our employees, and this award shows that we continue to be successful in our efforts for yet another year," said D

      12/7/21 9:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Carlyle Group Inc. disposed of $2,646,829,818 worth of shares (55,722,733 units at $47.50)

      4 - PPD, Inc. (0001793294) (Issuer)

      12/9/21 5:14:00 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: H&F Corporate Investors Viii, Ltd. sold $6,309,960,135 worth of shares (132,841,266 units at $47.50)

      4 - PPD, Inc. (0001793294) (Issuer)

      12/8/21 5:05:14 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: H&F Corporate Investors Vii, Ltd. sold $6,309,960,135 worth of shares (132,841,266 units at $47.50)

      4 - PPD, Inc. (0001793294) (Issuer)

      12/8/21 4:53:26 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    SEC Filings

    See more
    • SEC Form 15-12B filed by PPD, Inc.

      15-12B - PPD, Inc. (0001793294) (Filer)

      12/20/21 5:20:22 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form S-8 POS filed by PPD, Inc.

      S-8 POS - PPD, Inc. (0001793294) (Filer)

      12/8/21 4:16:02 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • PPD, Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - PPD, Inc. (0001793294) (Filer)

      12/8/21 4:12:04 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Leadership Updates

    Live Leadership Updates

    See more
    • Saama Appoints Scott Rogers as Company's Chief Financial Officer

      Scott brings a unique combination of financial and clinical fused with growth experience to Saama New CFO appointment follows October announcement of $430M growth investment Saama Technologies, Inc. ("Saama") today announced that Scott Rogers, 17-year industry veteran, has been appointed as the company's Chief Financial Officer, effective January 31, 2022. In this position Scott is responsible for leading the company's global finance organization and will report to Saama Founder and CEO Suresh Katta. Scott comes to Saama with significant financial executive experience in clinical development, commercial growth, and financial reporting and compliance. He progressed rapidly through the

      2/2/22 8:00:00 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by PPD, Inc.

      SC 13G - PPD, Inc. (0001793294) (Subject)

      12/9/21 5:06:56 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed

      SC 13G - PPD, Inc. (0001793294) (Subject)

      2/12/21 4:19:09 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed

      SC 13G - PPD, Inc. (0001793294) (Subject)

      2/12/21 6:11:58 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Credit Suisse resumed coverage on PPD with a new price target

      Credit Suisse resumed coverage of PPD with a rating of Neutral and set a new price target of $47.50

      8/5/21 6:25:35 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • PPD downgraded by JP Morgan with a new price target

      JP Morgan downgraded PPD from Overweight to Neutral and set a new price target of $48.00

      4/28/21 10:25:55 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • PPD downgraded by Jefferies

      Jefferies downgraded PPD from Buy to Hold

      4/20/21 8:11:33 AM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $PPD
    Financials

    Live finance-specific insights

    See more
    • PPD Announces Third Quarter 2021 Earnings Conference Call

      PPD, Inc. (NASDAQ:PPD), a leading global contract research organization, will host a conference call on Thursday, October 28, 2021, at 8 a.m. (U.S. Eastern Time) to discuss its third quarter 2021 financial results. Investors and other interested parties may listen to a live webcast of the conference call by logging on to the investors section of PPD's website at https://investors.ppd.com. An archived copy of the webcast will be available on the website after the call. In addition, the conference call can be accessed live over the phone by dialing +1 877 407 0784, or for international callers, +1 201 689 8560. A replay will be available after the call and can be accessed by dialing +1 844 5

      10/18/21 4:05:00 PM ET
      $PPD
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

      CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. Safety data continue to accrue and the study continues to be monitored by an independent, NIH-appointed Data Safety Monitoring Board (DSMB). The Company also announced that today, Moderna plans to request an Emergency Use Authorization (EUA) f

      11/30/20 6:59:00 AM ET
      $MRNA
      $PPD
      $MCK
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch
      Other Pharmaceuticals